| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $871M | $878M | $926M | -0.8% | -5.9% |
| Op. Income | $159M | $180M | $184M | -11.7% | -13.6% |
| Gross Margin | 35.5% | 38.4% | 37.5% | -2.9pp | -2.0pp |
| Net Margin | 1.4% | 7.3% | 3.6% | -5.9pp | -2.2pp |
| EPS (Diluted) | $0.14 | $0.76 | $0.36 | -81.6% | -61.1% |
| Free Cash Flow | $116M | $187M | $118M | -38.0% | -1.7% |
| Item | Amount |
|---|---|
| REVENUE | $871M |
| Cost of Revenue | $562M |
| GROSS PROFIT | $309M |
| R&D Expenses | $0 |
| Selling & Marketing | $238M |
| General & Administrative | $95M |
| SG&A Expenses | $333M |
| Other Expenses | -$183M |
| Operating Expenses | $150M |
| Cost & Expenses | $712M |
| OPERATING INCOME | $159M |
| Interest Income | -$11M |
| Interest Expense | $29M |
| Other Income/Expenses | -$136M |
| INCOME BEFORE TAX | $23M |
| Income Tax Expense | $11M |
| NET INCOME | $12M |
| D&A | $158M |
| EBIT | $159M |
| EBITDA | $317M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $871M |
| Cost of Revenue | $562M |
| GROSS PROFIT | $309M |
| R&D Expenses | $0 |
| Selling & Marketing | $238M |
| General & Administrative | $95M |
| SG&A Expenses | $333M |
| Other Expenses | -$183M |
| Operating Expenses | $150M |
| Cost & Expenses | $712M |
| OPERATING INCOME | $159M |
| Interest Income | -$11M |
| Interest Expense | $29M |
| Other Income/Expenses | -$136M |
| INCOME BEFORE TAX | $23M |
| Income Tax Expense | $11M |
| NET INCOME | $12M |
| D&A | $158M |
| EBIT | $159M |
| EBITDA | $317M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $12M |
| Depreciation & Amortization | $167M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $9M |
| Other Non-Cash Items | $24M |
| Change in Working Capital | $24M |
| OPERATING CASH FLOW | $236M |
| Capital Expenditure | -$120M |
| Acquisitions (Net) | -$434M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $46M |
| NET CASH FROM INVESTING | -$508M |
| Net Debt Issuance | $268M |
| Common Stock Repurchased | -$25M |
| Common Dividends Paid | -$34M |
| Other Financing Activities | -$2M |
| NET CASH FROM FINANCING | $208M |
| FREE CASH FLOW | $116M |
| Net Change in Cash | -$64M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $132M |
| Short-Term Investments | $0 |
| Net Receivables | $455M |
| Inventory | $106M |
| Other Current Assets | $207M |
| TOTAL CURRENT ASSETS | $938M |
| PP&E (Net) | $6.0B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $212M |
| Tax Assets | $76M |
| Other Non-Current Assets | $189M |
| TOTAL NON-CURRENT ASSETS | $6.5B |
| TOTAL ASSETS | $7.4B |
| Account Payables | $452M |
| Short-Term Debt | $15M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $424M |
| TOTAL CURRENT LIABILITIES | $1.1B |
| Long-Term Debt | $1.3B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $154M |
| Other Non-Current Liabilities | $1.2B |
| TOTAL NON-CURRENT LIABILITIES | $2.7B |
| TOTAL LIABILITIES | $3.7B |
| Common Stock | $1M |
| Additional Paid-In Capital | $2.6B |
| Retained Earnings | $1.9B |
| Treasury Stock | -$944M |
| Accum. Other Comp. Income | $87M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.7B |
| Minority Interest | $0 |
| TOTAL EQUITY | $3.7B |
| TOTAL LIABILITIES & EQUITY | $7.4B |
| Total Debt | $1.4B |
| Net Debt | $1.2B |
